Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
$3.65
+6.1%
$3.52
$3.96
$12.00
$6.54M1.557,305 shs2,461 shs
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
C$10.60
-3.8%
C$10.60
C$3.50
C$15.75
C$168.68MN/A12,671 shs3,402 shs
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
$11.11
$11.16
$9.90
$11.98
$36.77MN/A7,280 shs2 shs
IBT
IBEX Technologies
C$1.44
C$1.44
C$0.75
C$1.45
C$35.54M-0.0568,888 shs200 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
+6.10%+6.41%+1.11%+48.98%-46.95%
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.00%0.00%0.00%0.00%0.00%
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
0.00%0.00%0.00%0.00%0.00%
IBT
IBEX Technologies
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
N/AN/AN/AN/AN/AN/AN/AN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/AN/AN/AN/AN/A
IBT
IBEX Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
0.00
N/AN/AN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.00
N/AC$15.0041.51% Upside
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
0.00
N/AN/AN/A
IBT
IBEX Technologies
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
$2.37M2.76N/AN/A$14.99 per share0.24
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AC$3.34 per share3.17C$3.60 per shareN/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/A($1.84) per shareN/A
IBT
IBEX Technologies
C$5.77M6.15C$0.92 per share1.56C$0.58 per share2.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
-$16.55M-$14.86N/AN/A-760.32%-83.45%-45.76%8/11/2025 (Estimated)
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A-C$0.38N/AN/AN/AN/AN/AN/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
-$790KN/A0.00N/AN/AN/A-2.30%N/A
IBT
IBEX Technologies
C$3.10MC$0.1211.52N/A53.78%21.95%6.42%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
N/AN/AN/AN/AN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AN/AN/AN/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/AN/AN/AN/AN/A
IBT
IBEX Technologies
N/A3.11%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
N/A
5.94
5.93
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.05
129.63
128.68
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/A
0.01
0.01
IBT
IBEX Technologies
11.06
6.24
4.93

Institutional Ownership

CompanyInstitutional Ownership
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
0.73%
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
24.82%
IBT
IBEX Technologies
19.05%

Insider Ownership

CompanyInsider Ownership
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
0.10%
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
62.81%
IBT
IBEX Technologies
25.36%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aeterna Zentaris Inc. stock logo
AEZS
Aeterna Zentaris
201.79 million1.79 millionNo Data
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
515.91 millionN/ANot Optionable
Global System Dynamics, Inc. stock logo
GSD
Global System Dynamics
N/A3.31 million1.23 millionNot Optionable
IBT
IBEX Technologies
N/A24.68 millionN/ANot Optionable

Recent News About These Companies

IBEX Announces Record First Quarter of Fiscal Year 2025 Financial Results
IBT's financial year in review
ibex Launches Wave iX Translate
IBEX Completes Sale of the Company
IBEX Technologies Inc.
IBEX Technologies Inc (IBT) Earnings Dates & Reports
Closing Bell: Ibex Technologies Inc flat on Wednesday (IBT)
Closing Bell: Ibex Technologies Inc flat on Thursday (IBT)
Closing Bell: Ibex Technologies Inc down on Thursday (IBT)
Closing Bell: Ibex Technologies Inc up on Tuesday (IBT)
Mayfair Hits 52-Week High on News
IBEX Technologies Inc. (IBT.V)
Closing Bell: Ibex Technologies Inc up on Friday (IBT)
Closing Bell: Ibex Technologies Inc down on Friday (IBT)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aeterna Zentaris stock logo

Aeterna Zentaris NASDAQ:AEZS

$3.65 +0.21 (+6.10%)
As of 07/8/2025

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis. The company also has a license and research agreement with University of Wuerzburg to develop, manufacture, and commercialize AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Toronto, Canada.

BriaCell Therapeutics stock logo

BriaCell Therapeutics CVE:BCT

C$10.60 -0.42 (-3.81%)
As of 12/30/2021

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Global System Dynamics stock logo

Global System Dynamics NASDAQ:GSD

Global System Dynamics, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses its search on the farming and national security sectors, including farming related operations and businesses that support the farming industry. The company was formerly known as Gladstone Acquisition Corporation. Global System Dynamics, Inc. was incorporated in 2021 and is based in Houston, Texas.

IBEX Technologies CVE:IBT

C$1.44 0.00 (0.00%)
As of 04/5/2024

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.